{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:35:27Z","timestamp":1791246927290,"version":"4.1.0"},"reference-count":56,"publisher":"American Chemical Society (ACS)","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Chem."],"published-print":{"date-parts":[[2007,10,1]]},"DOI":"10.1021\/jm070714l","type":"journal-article","created":{"date-parts":[[2007,9,6]],"date-time":"2007-09-06T11:00:27Z","timestamp":1189076427000},"page":"5024-5033","source":"Crossref","is-referenced-by-count":64,"title":["High-Efficacy 5-HT<sub>1A<\/sub> Agonists for Antidepressant Treatment:\u2009 A Renewed Opportunity"],"prefix":"10.1021","volume":"50","author":[{"given":"Jean Louis","family":"Maurel","sequence":"first","affiliation":[{"name":"Task Force Chemistry, Medicinal Chemistry 1 Division, Neurobiology 2 Division, and Toulouse ISTMT 2, Pierre Fabre Research Center, 17 avenue Jean Moulin, 81106 Castres Cedex, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Autin","sequence":"additional","affiliation":[{"name":"Task Force Chemistry, Medicinal Chemistry 1 Division, Neurobiology 2 Division, and Toulouse ISTMT 2, Pierre Fabre Research Center, 17 avenue Jean Moulin, 81106 Castres Cedex, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Funes","sequence":"additional","affiliation":[{"name":"Task Force Chemistry, Medicinal Chemistry 1 Division, Neurobiology 2 Division, and Toulouse ISTMT 2, Pierre Fabre Research Center, 17 avenue Jean Moulin, 81106 Castres Cedex, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Newman-Tancredi","sequence":"additional","affiliation":[{"name":"Task Force Chemistry, Medicinal Chemistry 1 Division, Neurobiology 2 Division, and Toulouse ISTMT 2, Pierre Fabre Research Center, 17 avenue Jean Moulin, 81106 Castres Cedex, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Colpaert","sequence":"additional","affiliation":[{"name":"Task Force Chemistry, Medicinal Chemistry 1 Division, Neurobiology 2 Division, and Toulouse ISTMT 2, Pierre Fabre Research Center, 17 avenue Jean Moulin, 81106 Castres Cedex, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Vacher","sequence":"additional","affiliation":[{"name":"Task Force Chemistry, Medicinal Chemistry 1 Division, Neurobiology 2 Division, and Toulouse ISTMT 2, Pierre Fabre Research Center, 17 avenue Jean Moulin, 81106 Castres Cedex, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2007,9,6]]},"reference":[{"key":"jm070714lb00001\/jm070714lb00001_1","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1021\/jm9804329","volume":"41","author":"Vacher B.","year":"1998","journal-title":"J. Med. Chem."},{"key":"jm070714lb00001\/jm070714lb00001_2","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1021\/jm9806906","volume":"42","author":"Vacher B.","year":"1999","journal-title":"J. Med. Chem."},{"key":"jm070714lb00002\/jm070714lb00002_1","first-page":"47","volume":"7","author":"Colpaert F.","year":"2006","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"jm070714lb00003\/jm070714lb00003_1","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0028-3908(02)00119-3","volume":"43","author":"Colpaert F. C.","year":"2002","journal-title":"Neuropharmacology"},{"key":"jm070714lb00004\/jm070714lb00004_1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-2999(02)02640-7","volume":"456","author":"Deseure K. R.","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"jm070714lb00005\/jm070714lb00005_1","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1124\/jpet.103.050286","volume":"306","author":"Deseure K. R.","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"jm070714lb00006\/jm070714lb00006_1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2004.06.026","volume":"497","author":"Colpaert F. C.","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"jm070714lb00007\/jm070714lb00007_1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1021\/jm061015w","volume":"50","author":"Butera J. A","year":"2007","journal-title":"J. Med. Chem."},{"key":"jm070714lb00008\/jm070714lb00008_1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1471-4159.1981.tb02397.x","volume":"36","author":"Pedigo N. W.","year":"1981","journal-title":"J. Neurochem."},{"key":"jm070714lb00009\/jm070714lb00009_1","volume-title":"Drugs Future","author":"Examples","year":"2004"},{"key":"jm070714lb00010\/jm070714lb00010_1","unstructured":"Buspirone:\u2009 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-8-azaspiro(4.5)decane-7,9-dione, [36505-84-7]."},{"key":"jm070714lb00011\/jm070714lb00011_1","unstructured":"Tandospirone:\u2009 4,7-methano-1H-isoindole-1,3(2H)-dione, hexahydro-2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)- (3a\u03b1,4\u03b2,7\u03b2,7a\u03b1)- 2-hydroxy-1,2,3-propanetricarboxylate, [112457-95-1]."},{"key":"jm070714lb00012\/jm070714lb00012_1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0014-2999(01)01011-1","volume":"420","author":"Koek W.","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"jm070714lb00013\/jm070714lb00013_1","first-page":"31","volume":"18","author":"Appert-Collin A.","year":"2005","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"jm070714lb00015\/jm070714lb00015_1","first-page":"1504","volume":"349","author":"Murray C. J. L.","year":"1997","journal-title":"Lancet"},{"key":"jm070714lb00016\/jm070714lb00016_1","volume-title":"Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine. Pierre Fabre Medicament WO\/9822459","author":"Also","year":"1998"},{"key":"jm070714lb00017\/jm070714lb00017_1","unstructured":"Methyl 2-(methylsulfonyl)pyrimidine-5-carboxylate, [38275-49-9]."},{"key":"jm070714lb00018\/jm070714lb00018_1","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1248\/cpb.48.1504","volume":"48","author":"Ohta K.","year":"2000","journal-title":"Chem. Pharm. Bull."},{"key":"jm070714lb00019\/jm070714lb00019_1","unstructured":"2-Chloro-4-(methylamino)pyrimidine, [66131-68-8]."},{"key":"jm070714lb00020\/jm070714lb00020_1","unstructured":"5-Chloro-2-(methylsulfonyl)-4-pyrimidinecarboxylic acid, [38275-34-2]."},{"key":"jm070714lb00021\/jm070714lb00021_1","first-page":"887","volume":"47","author":"Pie P. A.","year":"2004","journal-title":"J. Med. Chem."},{"key":"jm070714lb00022\/jm070714lb00022_1","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.1016\/S0040-4039(99)01471-9","volume":"40","author":"Lange U. E. W.","year":"1999","journal-title":"Tetrahedron Lett."},{"key":"jm070714lb00023\/jm070714lb00023_1","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1021\/jo00037a012","volume":"57","author":"Stolle W. A. W.","year":"1992","journal-title":"J. Org. Chem."},{"key":"jm070714lb00024\/jm070714lb00024_1","unstructured":"2-Cyano-5-methylpyrazine, [98006-91-8]."},{"key":"jm070714lb00025\/jm070714lb00025_1","unstructured":"3-Cyano-6-methylpyridazine, [49840-90-6]."},{"key":"jm070714lb00026\/jm070714lb00026_1","unstructured":"5-Aminomethyl-2-methylpyrazine, [132664-85-8]."},{"key":"jm070714lb00027\/jm070714lb00027_1","unstructured":"(a) 5-Chloro-2-pyridinecarboxaldehyde, [31181-89-2]. (b) 5-(Hydroxymethyl)-2-pyridinecarboxaldehyde, [40749-33-5]. (c) 5-Fluoromethylpyridine-2-carboxaldehyde, [635323-74-9]."},{"key":"jm070714lb00028\/jm070714lb00028_1","unstructured":"Ethyl 6-(hydroxymethyl)nicotinate, [35005-81-3]."},{"key":"jm070714lb00029\/jm070714lb00029_1","first-page":"212","volume":"6","author":"Liu Y.","year":"2004","journal-title":"Org. Lett."},{"key":"jm070714lb00030\/jm070714lb00030_1","unstructured":"4-(Fur-2-yl)-2-methyl-pyrimidine, [28565-17-5]."},{"key":"jm070714lb00034\/jm070714lb00034_1","unstructured":"8-OH-DPAT:\u2009 8-hydroxy-2-dipropylaminotetralin, [76135-31-4]."},{"key":"jm070714lb00035\/jm070714lb00035_1","first-page":"86","volume":"8","author":"de Paulis T.","year":"2007","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"jm070714lb00035\/jm070714lb00035_2","first-page":"3135","volume":"49","author":"Becker O. M.","year":"2006","journal-title":"J. Med. Chem."},{"key":"jm070714lb00036\/jm070714lb00036_1","first-page":"1288","volume":"139","author":"Flibanserin","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"jm070714lb00037\/jm070714lb00037_1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/PL00005090","volume":"356","author":"Pauwels P. J.","year":"1997","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"jm070714lb00038\/jm070714lb00038_1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/0014-2999(84)90714-3","volume":"106","author":"Tricklebank M. D.","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"jm070714lb00038\/jm070714lb00038_2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ddr.430260103","volume":"26","author":"Colpaert F. C.","year":"1992","journal-title":"Drug Dev. Res."},{"key":"jm070714lb00042\/jm070714lb00042_1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.euroneuro.2006.03.002","volume":"17","author":"Belozertseva I. V.","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"jm070714lb00042\/jm070714lb00042_2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0014-2999(78)90118-8","volume":"47","author":"Porsolt R. D.","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"jm070714lb00043\/jm070714lb00043_1","volume-title":"a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential. J. Pharmacol. Exp. Ther","author":"Koek W.","year":"1998"},{"key":"jm070714lb00044\/jm070714lb00044_1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s002130100876","volume":"159","author":"Borsini F.","year":"2001","journal-title":"Psychopharmacology"},{"key":"jm070714lb00045\/jm070714lb00045_1","volume-title":"A.","author":"The","year":"2006"},{"key":"jm070714lb00046\/jm070714lb00046_1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/BF00179315","volume":"338","author":"Hjorth S.","year":"1988","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"jm070714lb00047\/jm070714lb00047_1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00210-004-1005-7","volume":"371","author":"Sullivan N. R.","year":"2005","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"jm070714lb00048\/jm070714lb00048_1","first-page":"1021","volume":"70","author":"Mannoury la Cour C.","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"jm070714lb00049\/jm070714lb00049_1","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1176\/ajp.122.5.509","volume":"122","author":"Schildkraut J. J","year":"1965","journal-title":"Am. J. Psychiatry"},{"key":"jm070714lb00050\/jm070714lb00050_1","first-page":"4290","volume":"33","author":"Gettys T. W.","year":"1994","journal-title":"Biochemistry"},{"key":"jm070714lb00051\/jm070714lb00051_1","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.biopsych.2006.05.015","volume":"61","author":"Dremencov E.","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"jm070714lb00051\/jm070714lb00051_2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0924-977X(02)00173-6","volume":"13","author":"Blier P","year":"2003","journal-title":"Eur. Neuropsychopharmacol."},{"key":"jm070714lb00052\/jm070714lb00052_1","unstructured":"2-Pyrimidinemethanamine, [75985-45-4]."},{"key":"jm070714lb00053\/jm070714lb00053_1","unstructured":"5-Chloro-2-pyrimidinemethanamine, [426266-77-5]."},{"key":"jm070714lb00054\/jm070714lb00054_1","unstructured":"4-Methoxy-2-pyrimidinemethanamine, [909563-18-4]."},{"key":"jm070714lb00055\/jm070714lb00055_1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1017\/S1461145704005000","volume":"8","author":"Newman-Tancredi A.","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"jm070714lb00056\/jm070714lb00056_1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0160-5402(85)90034-8","volume":"14","author":"McPherson G. A","year":"1985","journal-title":"J. Pharmacol. Methods"},{"key":"jm070714lb00057\/jm070714lb00057_1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0014-2999(95)00324-E","volume":"281","author":"Kleven M.","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"jm070714lb00058\/jm070714lb00058_1","volume-title":"Manual of Pharmacologic Calculations with Computer Programs","author":"Tallarida R. J.","year":"1987","edition":"2"}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/jm070714l","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T06:11:17Z","timestamp":1634451077000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/jm070714l"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,6]]},"references-count":56,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2007,10,1]]}},"alternative-id":["10.1021\/jm070714l"],"URL":"https:\/\/doi.org\/10.1021\/jm070714l","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,6]]}}}